Trial site
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
- 386running trials
- 115closed trials
The trials here
What the 506 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma47 trials
- Lung cancer37 trials
- Acute myeloid leukaemia33 trials
- Childhood cancers32 trials
- Metastatic breast cancer24 trials
- Myeloproliferative neoplasms23 trials
- Acute lymphoblastic leukaemia22 trials
- Follicular lymphoma20 trials
- Hodgkin lymphoma19 trials
- Ovarian cancer19 trials
- Chronic kidney disease16 trials
- Liver and biliary tract cancer16 trials
- and 73 more
- Phase
- Phase 3268 trials
- Phase 2133 trials
- Phase 1/246 trials
- Phase 126 trials
- Phase 2/320 trials
- Phase 413 trials
- Status
- Recruiting170 trials
- Active, not recruiting167 trials
- Completed115 trials
- Not yet recruiting49 trials
- Suspended5 trials
- Lead sponsor
- AstraZeneca27 trials
- Merck Sharp & Dohme LLC20 trials
- AbbVie17 trials
- Pfizer14 trials
- Hoffmann-La Roche12 trials
- and 209 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Recruiting
Recruiting
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Showing 50 of 386.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer21 recruiting
- Acute myeloid leukaemia17 recruiting
- Childhood cancers17 recruiting
- Multiple myeloma16 recruiting
- Acute lymphoblastic leukaemia10 recruiting
- Metastatic breast cancer9 recruiting
- Myelodysplastic syndromes9 recruiting
- Myeloproliferative neoplasms9 recruiting
- Ovarian cancer9 recruiting
- Pancreatic cancer9 recruiting
- Crohn's disease8 recruiting
- Endometrial cancer8 recruiting
- Fatty liver disease (MASLD/MASH)8 recruiting
- Hodgkin lymphoma8 recruiting
- Kidney cancer7 recruiting
- Follicular lymphoma6 recruiting
- Liver and biliary tract cancer6 recruiting
- Mantle cell lymphoma6 recruiting
- Prostate cancer6 recruiting
- Chronic lymphocytic leukaemia5 recruiting
- Chronic myeloid leukaemia5 recruiting
- Colorectal cancer5 recruiting
- Immune thrombocytopenia (ITP)5 recruiting
- Obesity5 recruiting
- Type 2 diabetes5 recruiting
- Ulcerative colitis5 recruiting
- Amyloidosis4 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Heart failure4 recruiting
- High blood pressure4 recruiting
- Idiopathic pulmonary fibrosis4 recruiting
- Liver cirrhosis4 recruiting
- Bladder cancer3 recruiting
- Head and neck cancer3 recruiting
- Triple-negative breast cancer3 recruiting
- Type 1 diabetes3 recruiting
- Chronic kidney disease2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Gastric and oesophageal cancer2 recruiting
- IgA nephropathy2 recruiting
- Neuroendocrine tumours2 recruiting
- Alopecia areata1 recruiting
- ANCA-associated vasculitis1 recruiting
- Atrial fibrillation1 recruiting
- Bronchiectasis1 recruiting
- Cervical cancer1 recruiting
- Coeliac disease1 recruiting
- COPD1 recruiting
- Cushing's syndrome1 recruiting
- Cystic fibrosis1 recruiting
- Cytomegalovirus infection1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Epidermolysis bullosa1 recruiting
- Glioblastoma1 recruiting
- Graves' disease1 recruiting
- Lupus (SLE)1 recruiting
- Mesothelioma1 recruiting
- Myasthenia gravis1 recruiting
- Myocarditis1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
- Psoriasis1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thalassaemia1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Withdrawn
Completed
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
Active, not recruiting
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Completed
A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Recruiting
Completed
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Completed
Completed
Active, not recruiting
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
Active, not recruiting
A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
Completed
Completed
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis
Completed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Terminated
Completed
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Completed
Completed
Completed
Completed
Completed
Completed
GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer
Completed
Active, not recruiting
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Terminated
Showing 50 of 115.
Site data: ClinicalTrials.govUpdated 19 Nov 2026